Literature DB >> 25832723

Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation.

Krista L Lentine1, Ngan N Lam, Huiling Xiao, Janet E Tuttle-Newhall, David Axelrod, Daniel C Brennan, Vikas R Dharnidharka, Hui Yuan, Mustafa Nazzal, Jie Zheng, Mark A Schnitzler.   

Abstract

BACKGROUND: The impact of narcotic use before kidney transplantation on post-transplant clinical outcomes is not well described.
METHODS: We examined integrated national transplant registry, pharmacy records, and Medicare billing claims to follow 16,322 kidney transplant recipients, of whom 28.3% filled a narcotic prescription in the year before transplantation. Opioid analgesic fills were normalized to morphine equivalents (ME) and expressed as mg/kg exposures (approximate quartiles: 0.1-1.7, 1.8-5.4, 5.5-23.7, and ≥ 23.8 mg/kg, respectively). Post-transplant cardiovascular, respiratory, neurological, accidents, substance abuse, and noncompliance events were identified using diagnosis codes on Medicare billing claims. Adjusted associations of ME level with post-transplant complications were quantified by multivariate Cox regression.
RESULTS: The incidence of complications at 3 years post-transplant among those with the highest pre-transplant ME exposure compared to no use included: ventricular arrhythmias, 1.1 vs. 0.2% (p < 0.001); cardiac arrest, 4.7 vs. 2.7% (p < 0.05); hypotension, 14 vs. 8% (p < 0.0001); hypercapnia, 1.6 vs. 0.9% (p < 0.05); mental status changes, 5.3 vs. 2.7% (p < 0.001); drug abuse/dependence, 7.0 vs. 1.7% (p < 0.0001); alcohol abuse, 1.8 vs. 0.6% (p = 0.0001); accidents, 0.9 vs. 0.3% (p < 0.05); and noncompliance, 3.5 vs. 2.3% (p < 0.05). In multivariate analyses, transplant recipients with the highest level of pre-transplant narcotic use had approximately 2 to 4 times the risks of post-transplant ventricular arrhythmias, mental status changes, drug abuse, alcohol abuse, and accidents compared with non-users, and 35-45% higher risks of cardiac arrest and hypotension.
CONCLUSION: Although associations may reflect underlying conditions or behaviors, high-level prescription narcotic use before kidney transplantation predicts increased risk of clinical complications after transplantation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832723      PMCID: PMC4522162          DOI: 10.1159/000377685

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  27 in total

1.  Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.

Authors:  Adrian R Levy; Bernie J O'Brien; Connie Sellors; Paul Grootendorst; Donald Willison
Journal:  Can J Clin Pharmacol       Date:  2003

Review 2.  Opioids in renal failure and dialysis patients.

Authors:  Mervyn Dean
Journal:  J Pain Symptom Manage       Date:  2004-11       Impact factor: 3.612

3.  Factors contributing to acute rejection in renal transplantation: the role of noncompliance.

Authors:  P E Morrissey; S Reinert; A Yango; A Gautam; A Monaco; R Gohh
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

4.  Recording of drug prescriptions in the county of Jämtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy.

Authors:  G Boethius
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

5.  Validation of pharmacy records in drug exposure assessment.

Authors:  H S Lau; A de Boer; K S Beuning; A Porsius
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

6.  Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data.

Authors:  Krista L Lentine; Hui Yuan; Janet E Tuttle-Newhall; Huiling Xiao; Vikram Chawa; David Axelrod; Daniel C Brennan; Vikas R Dharnidharka; Christopher Beuer; Mark A Schnitzler
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

Review 7.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Authors:  Eija Kalso; Jayne E Edwards; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

8.  Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.

Authors:  S De Geest; L Borgermans; H Gemoets; I Abraham; H Vlaminck; G Evers; Y Vanrenterghem
Journal:  Transplantation       Date:  1995-02-15       Impact factor: 4.939

Review 9.  Pain in hemodialysis patients: prevalence, cause, severity, and management.

Authors:  Sara N Davison
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

Review 10.  Analgesia in patients with ESRD: a review of available evidence.

Authors:  Manjula Kurella; William M Bennett; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

View more
  18 in total

1.  Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Authors:  Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler
Journal:  Transpl Int       Date:  2017-08-03       Impact factor: 3.782

2.  Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients.

Authors:  Kevin C Abbott; Chyng-Wen Fwu; Paul W Eggers; Anne W Eggers; Prudence P Kline; Paul L Kimmel
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

3.  Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.

Authors:  Luke S Vest; Nagaraju Sarabu; Farrukh M Koraishy; Minh-Tri Nguyen; Meyeon Park; Ngan N Lam; Mark A Schnitzler; David Axelrod; Chi Yuan Hsu; Amit X Garg; Dorry L Segev; Allan B Massie; Gregory P Hess; Bertram L Kasiske; Krista L Lentine
Journal:  Clin Transplant       Date:  2020-06-29       Impact factor: 2.863

4.  Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes.

Authors:  K L Lentine; N N Lam; A S Naik; D A Axelrod; Z Zhang; V R Dharnidharka; G P Hess; D L Segev; R Ouseph; H Randall; T Alhamad; R Devraj; R Gadi; B L Kasiske; D C Brennan; M A Schnitzler
Journal:  Am J Transplant       Date:  2018-04-17       Impact factor: 8.086

5.  Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes.

Authors:  Krista L Lentine; Kevin S Shah; Jon A Kobashigawa; Huiling Xiao; Zidong Zhang; David A Axelrod; Ngan N Lam; Dorry L Segev; Mara Ann McAdams-DeMarco; Henry Randall; Gregory P Hess; Hui Yuan; Luke S Vest; Bertram L Kasiske; Mark A Schnitzler
Journal:  Am J Transplant       Date:  2019-09-12       Impact factor: 8.086

6.  Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients.

Authors:  Marie A Chisholm-Burns; Christina A Spivey; Praveen K Potukuchi; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Nephron       Date:  2020-05-20       Impact factor: 2.847

7.  Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes.

Authors:  Tarek Alhamad; Farrukh M Koraishy; Ngan N Lam; Sreelatha Katari; Abhijit S Naik; Mark A Schnitzler; Huiling Xiao; David A Axelrod; Vikas R Dharnidharka; Henry Randall; Rosemary Ouseph; Dorry L Segev; Daniel C Brennan; Radhika Devraj; Bertram L Kasiske; Krista L Lentine
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

8.  Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Authors:  Tarek Alhamad; Daniel C Brennan; Zaid Brifkani; Huiling Xiao; Mark A Schnitzler; Vikas R Dharnidharka; David Axelrod; Dorry L Segev; Krista L Lentine
Journal:  Transplantation       Date:  2016-05       Impact factor: 4.939

9.  Gender differences in use of prescription narcotic medications among living kidney donors.

Authors:  Krista L Lentine; Ngan N Lam; Mark A Schnitzler; Amit X Garg; Huiling Xiao; Sheila E Leander; Daniel C Brennan; Sandra J Taler; David Axelrod; Dorry L Segev
Journal:  Clin Transplant       Date:  2015-09-18       Impact factor: 2.863

10.  Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients.

Authors:  Ngan N Lam; Mark A Schnitzler; David A Axelrod; Huiling Xiao; Mara McAdams-DeMarco; Dorry L Segev; Allan B Massie; Vikas R Dharnidharka; Abhijit S Naik; Abimereki D Muzaale; Gregory P Hess; Bertram L Kasiske; Krista L Lentine
Journal:  Clin Transplant       Date:  2020-08-03       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.